Detalhe da pesquisa
1.
Race, rituximab, and relapse in TTP.
Blood
; 140(12): 1335-1344, 2022 09 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35797471
2.
How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns.
Blood
; 134(5): 415-420, 2019 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31217190
3.
The impact of TTP in the brain.
Blood
; 142(4): 307-308, 2023 07 27.
Artigo
Inglês
| MEDLINE | ID: mdl-37498586
4.
The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis.
Blood
; 132(9): 903-910, 2018 08 30.
Artigo
Inglês
| MEDLINE | ID: mdl-30006329
5.
None of the above: thrombotic microangiopathy beyond TTP and HUS.
Blood
; 129(21): 2857-2863, 2017 05 25.
Artigo
Inglês
| MEDLINE | ID: mdl-28416509
6.
Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpura.
Br J Haematol
; 189(1): e18-e20, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32065383
7.
When you think you should transfuse don't!
Lab Med
; 2024 Apr 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38581079
8.
Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study.
J Thromb Haemost
; 22(2): 503-515, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37918635
9.
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura.
Res Pract Thromb Haemost
; 8(3): 102388, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38651093
10.
No major differences in outcomes between the initial and relapse episodes in patients with thrombotic thrombocytopenic purpura: The experience from the Ohio State University Registry.
Am J Hematol
; 93(3): E73-E75, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29226481
11.
Five years of caplacizumab - lessons learned and remaining controversies in immune-mediated thrombotic thrombocytopenic purpura.
J Thromb Haemost
; 21(10): 2718-2725, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37562668
12.
Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease.
J Thromb Haemost
; 21(10): 2953-2962, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37394119
13.
Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease.
J Thromb Haemost
; 20(8): 1910-1919, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35735219
14.
A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH.
Res Pract Thromb Haemost
; 6(6): e12786, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36032214
15.
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry.
Blood Adv
; 8(3): 620-623, 2024 02 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38100454
16.
Should older patients with low weight and CKD receive full-dose DOACs for treatment of acute proximal DVT?
Hematology Am Soc Hematol Educ Program
; 2023(1): 614-616, 2023 Dec 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38066903
17.
Novel therapies in thrombotic thrombocytopenic purpura.
Res Pract Thromb Haemost
; 2(1): 19-26, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30046703
18.
Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura.
Blood Adv
; 1(23): 2075-2082, 2017 Oct 24.
Artigo
Inglês
| MEDLINE | ID: mdl-29296854